Combined oral contraceptives and depressive disorders
Sulima A.N., Stroevsky V.V., Rumyantseva Z.S., Bakharovskaya A.S.
In recent years, there has been a growing interest in studying the effects of combined oral contraceptives (COCs) on women’s mental health, particularly on the development of depressive disorders. Research findings suggest that some women taking COCs may experience mood changes, as well as depressive symptoms. The mechanisms underlying this connection may involve hormonal changes that affect neurotransmitters such as serotonin and dopamine, which play a key role in mood regulation. Despite this, research findings are controversial. Some women do not experience any negative effects from taking COCs, and in some cases there is even an improvement in psychoemotional state. This article presents a review of up-to-date Russian and foreign literature available in the following open sources: eLibrary (scientometric database), CyberLeninka (scientific electronic library), PubMed (English-language text database of medical and biological publications).
Conclusion: The relationship between COCs and depressive disorders is complex and requires further research. The above sources demonstrate both positive and negative effects of hormonal contraception on women’s mental health. Therefore, additional research into this issue is necessary.
Authors’ contributions: Sulima A.N., Stroevsky V.V., Rumyantseva Z.S. – developing the concept and design of the study, editing the article; Bakharovskaya A.S.: collecting and processing the material, writing the text.
Conflicts of interest: Authors declare lack of the possible conflicts of interest.
Funding: The study was conducted without sponsorship.
For citation: Sulima A.N., Stroevsky V.V., Rumyantseva Z.S., Bakharovskaya A.S.
Combined oral contraceptives and depressive disorders.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2025; (4): 33-35 (in Russian)
https://dx.doi.org/10.18565/aig.2024.319
Keywords
combined oral contraceptives
depressive disorder
estrogens
progesterone
neurotransmitters
References
- Манухин И.Б., Геворкян Е.И., Манухина Е.И. Гинекологическая эндокринология. Клинические лекции. 5-е изд. М.: ГЭОТАР-Медиа; 2024. 304 с. [Manukhin I.B., Gevorkyan E.I., Manukhina E.I. Gynecological endocrinology. Clinical lectures. 5th ed. Moscow: GEOTAR-Media; 2024. 304 p. (in Russian)].
- Савельева Г.М., Сухих Г.Т., Манухин И.Б., ред. Гинекология. Национальное руководство. Краткое издание. М.: ГЭОТАР-Медиа; 2013. 704 с. [Savelyeva G.M., Sukhikh G.T., Manukhin I.B., ed. Gynecology. National Guide. Brief edition. Moscow: GEOTAR-Media; 2013. 704 p. (in Russian)].
- Кузнецова И.В., Бурчаков Д.И. Управление менструальным циклом – новая концепция применения комбинированных оральных контрацептивов. Акушерство и гинекология. 2016; 10: 132-7. [Kuznetsova I.V., Burchakov D.I. Control of the menstrual cycle: A new concept of the use of combined oral contraceptives. Obstetrics and Gynecology. 2016; (10): 132-7.
- (in Russian)]. https://dx.doi.org/10.18565/aig.2016.10.132-37.
- Коновалов В.А., Кузнецова И.В. Комбинированная оральная контрацепция как метод сохранения репродуктивного здоровья. Акушерство и гинекология. 2014; 12: 42-7. [Konovalov V.A., Kuznetsova I.V. Combined oral contraception as a method of preserving reproductive health. Obstetrics and Gynecology. 2014; (12): 42-7. (in Russian)].
- Jaafar K., Nabhan E., Daoud R., Nasser Z. Prevalence of anxiety and depression among Lebanese women using oral contraceptives: a cross-sectional study. BMC Womens Health. 2024; 24(1): 47. https://dx.doi/org/10.1186/s12905-024-02897-4.
- Hall K.S., Moreau C., Trussell J., Barber J. Role of young women's depression and stress symptoms in their weekly use and nonuse of contraceptive methods. J. Adolesc. Health. 2013; 53(2): 241-8. https://dx.doi/org/10.1016/j.jadohealth.2013.02.009.
- Gingnell M., Engman J., Frick A., Moby L., Wikström J., Fredrikson M. et al. Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill – a double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive. Psychoneuroendocrinology. 2013; 38(7): 1133-44. https://dx.doi/org/10.1016/j.psyneuen.2012.11.006.
- Hall K.S., O'Connell K.W., Rickert V.I., Reame N., Westhoff C. Influence of depressed mood and psychological stress symptoms on perceived oral contraceptive side effects and discontinuation in young minority women. Contraception. 2012; 86(5): 518-25. https://dx.doi/org/10.1016/j.contraception.2012.04.010.
- Hall K.S., Steinberg J.R., Cwiak C.A., Allen R.H., Marcus S.M. Contraception and mental health: a commentary on the evidence and principles for practice. Am. J. Obstet. Gynecol. 2015; 212(6): 740-6. https://dx.doi/org/10.1016/j.ajog.2014.12.010.
- Toffol E., Heikinheimo O., Koponen P., Luoto R., Partonen T. Further evidence for lack of negative associations between hormonal contraception and mental health. Contraception. 2012; 86: 470-80. https://dx.doi/org/10.1016/j.contraception.2012.02.014.
- Keyes K.M., Cheslack-Postava K., Westhoff C., Heim C.M., Haloossim M., Walsh K. et al. Association of hormonal contraceptive use with reduced levels of depressive symptoms: A national study of sexually active women in the United States. Am. J. Epidemiol. 2013; 178: 1378-88. https://dx.doi/org/10.1093/aje/kwt188.
- de Wit A.E., Booij S.H., Giltay E.J., Joffe H., Schoevers R.A., Oldehinkel A.J. Association of use of oral contraceptives with depressive symptoms among adolescents and young women. JAMA Psychiatry. 2020; 77(1): 52-9. https://dx.doi/org/10.1001/jamapsychiatry.2019.2838.
- Toffoletto S., Lanzenberger R., Gingnell M., Sundström-Poromaa I., Comasco E. Emotional and cognitive functional imaging of estrogen and progesterone effects in the female human brain: a systematic review. Psychoneuroendocrinology. 2014; 50: 28-52. https://dx.doi/org/10.1016/j.psyneuen.2014.07.025.
- Del Río J.P., Alliende M.I., Molina N., Serrano F.G., Molina S., Vigil P. Steroid hormones and their action in women's brains: the importance of hormonal balance. Front. Public Health. 2018; 6: 141. https://dx.doi/org/10.3389/fpubh.2018.00141.
- Mu E., Kulkarni J. Hormonal contraception and mood disorders. Aust. Prescr. 2022; 45(3): 75-9. https://dx.doi/org/10.18773/austprescr.2022.025.
- Li R., Singh M. Sex differences in cognitive impairment and Alzheimer’s disease. Front. Neuroendocrinol. 2014; 35(3): 385-403. https://dx.doi/org/10.1016/j.yfrne.2014.01.002.
- Rettberg J.R., Yao J., Brinton R.D. Estrogen: a master regulator of bioenergetic systems in the brain and body. Front. Neuroendocrinol. 2014; 35(1): 8-30. https://dx.doi/org/10.1016/j.yfrne.2013.08.001.
- Arevalo M.A., Azcoitia I., Garcia-Segura L.M. The neuroprotective actions of oestradiol and oestrogen receptors. Nat. Rev. Neurosci. 2014; 16(1): 17-29. https://dx.doi/org/10.1038/nrn3856.
- Schumacher M., Mattern С., Ghoumari A., Oudinet J.P., Liere P., Labombarda F. et al. Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors. Prog. Neurobiol. 2014; 113: 6-39. https://dx.doi/org/10.1016/j.pneurobio.2013.09.004.
- Skovlund C.W., Mørch L.S., Kessing L.V., Lidegaard Ø. Association of hormonal contraception with depression. JAMA Psychiatry. 2016; 73(11): 1154-62. https://dx.doi/org/10.1001/jamapsychiatry.2016.2387.
- Козлов П.В. Регуляция женского сексуального поведения и возможности медикаментозной терапии. Медицинский совет. 2023; 17(5): 15-20. [Kozlov P.V. Regulation of female sexual behavior and the possibilities of drug therapy. Medical Council. 2023; 17(5): 15-20. (in Russian)]. https://dx.doi/org/10.21518/ms2023-063.
- Mukherjee J., Cardarelli R.A., Cantaut-Belarif Y., Deeb T.Z., Srivastava D.P., Tyagarajan S.K. et al. Estradiol modulates the efficacy of synaptic inhibition by decreasing the dwell time of GABA receptors at inhibitory synapses. Proc. Natl. Acad. Sci. U. S. A. 2017; 114(44): 11763-8. https://dx.doi/org/10.1073/pnas.1705075114.
- Каркусова М.Д. Биологические эффекты серотонина (обзорная статья). Вестник новых медицинских технологий. 2022; 16(6): 133-9. [Karkusova M.D. Biological effects of serotonin (review article). Bulletin of New Medical Technologies. 2022; 16(6): 133-9. (in Russian)]. https://dx.doi/org/10.24412/2075-4094-2022-6-3-12.
- Паневин Т.С., Бобкова А.О., Каратеев А.Е, Зоткин Е.Г. Дефицит эндогенных эстрогенов и развитие хронической скелетно-мышечной боли. Терапевтический архив. 2022; 94(5): 683-8. [Panevin T.S., Bobkova A.O., Karateev A.E, Zotkin E.G. Endogenous estrogen deficiency and the development of chronic musculoskeletal pain: A review. Terapevticheskii Arkhiv. 2022; 94(5): 683-8. (in Russian)]. https://dx.doi/org/10.26442/00403660.2022.05.201490.
- Карпова И.В., Прошин С.Н., Глушаков Р.И., Михеев В.В., Бычков Е.Р. Половые различия по содержанию моноаминов в симметричных структурах мозга мышей линии С3 Н-А. Педиатр. 2014; 5(2): 56-64. [Karpova I.V., Proshin S.N., Glushakov R.I., Mikheev V.V., Bychkov E.R. Sex differences of the content on the monoamines levels in symmetrical structures of the C3 H-A mice brain. Pediatr (Pediatrician). 2014; 5(2):56-64. (in Russian)].
- Andréen L., Nyberg S., Turkmen S., van Wingen G., Fernández G., Bäckström T. Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators. Psychoneuroendocrinology. 2009; 34(8): 1121-32. https://dx.doi/org/10.1016/j.psyneuen.2009.02.003.
- Hausmann M., Güntürkün O. Steroid fluctuations modify functional cerebral asymmetries: the hypothesis of progesterone-mediated interhemispheric decoupling. Neuropsychologia. 2000; 38(10): 1362-74. https://dx.doi/org/10.1016/S0028-3932(00)00045-2.
- Bengtsdotter H., Lundin C., Gemzell Danielsson K., Bixo M., Baumgart J., Marions L. et al. Ongoing or previous mental disorders predispose to adverse mood reporting during combined oral contraceptive use. Eur. J. Contracept. Reprod. Health Care. 2018; 23(1): 45-51. https://dx.doi/org/10.1080/13625187.2017.1422239.
- Segebladh B., Borgström A., Odlind V., Bixo M., Sundström-Poromaa I. Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives. Contraception. 2009; 79(1): 50-5. https://dx.doi/org/10.1016/j.contraception.2008.08.001.
- Yusuf A.M., Warsame M.O., Gedi S., Abdullahi N.A., Ahmed D.I. Prevalence of depression among women using hormonal contraceptives in Mogadishu, Somalia: a cross-sectional study. Open Access J. Contracept. 2024; 15: 89-98. https://dx.doi/org/10.2147/OAJC.S444545.
- Déa C.A., Moreira E.C.H., Zamboti C.L. Sexual function, quality of life, anxiety, and depression in women of reproductive age using hormonal, nonhormonal, and no contraceptive methods. J. Sex. Med. 2024; 21(8): 683-90. https://dx.doi/org/10.1093/jsxmed/qdae060.
- Lundin C., Wikman A., Lampa E., Bixo M., Gemzell-Danielsson K., Wikman P. et al. There is no association between combined oral hormonal contraceptives and depression: a Swedish register-based cohort study. BJOG. 2022; 129(6): 917-25. https://dx.doi/org/10.1111/1471-0528.17028.
- McKetta S., Keyes K.M. Oral contraceptive use and depression among adolescents. Ann. Epidemiol. 2019; 29: 46-51. https://dx.doi/org/10.1016/j.annepidem.2018.10.002.
- Johansson T., Vinther Larsen S., Bui M., Ek W.E., Karlsson T., Johansson Å. Population-based cohort study of oral contraceptive use and risk of depression. Epidemiol. Psychiatr. Sci. 2023; 32: e39. https://dx.doi/org/10.1017/S2045796023000525.
- Anderl C., Li G., Chen F.S. Oral contraceptive use in adolescence predicts lasting vulnerability to depression in adulthood. J. Child. Psychol. Psychiatry. 2020; 61(2): 148-56. https://dx.doi/org/10.1111/jcpp.13115.
Received 12.12.2024
Accepted 21.03.2025
About the Authors
Anna N. Sulima, Dr. Med. Sci., Professor, Professor at the Department of Obstetrics, Gynecology and Perinatology No. 1, Medical Institute named after S.I. Georgievsky ofV.I. Vernadsky Crimean Federal University, 295051, Russia, Republic of Crimea, Simferopol, Lenin blvd., 5/7, +7(978)764-82-00, gsulima@yandex.ru,
https://orcid.org/0000-0002-2671-6985
Vladimir V. Stroevsky, PhD, Associate Professor at the Department of Psychiatry, Narcology, Psychotherapy with a Course in General and Medical Psychology, Medical Institute named after S.I. Georgievsky of V.I. Vernadsky Crimean Federal University, 295051, Russia, Republic of Crimea, Simferopol, Lenin blvd., 5/7, +7(978)812-65-08, vladimir.stroevskii@mail.ru, https://orcid.org/0000-0002-3028-0598
Zoya S. Rumyantseva, PhD, Associate Professor at the Department of Obstetrics, Gynecology and Perinatology No. 1, Medical Institute named after S.I. Georgievsky of
V.I. Vernadsky Crimean Federal University, 295051, Russia, Republic of Crimea, Simferopol, Lenin blvd., 5/7, +7(978)855-85-37, zoyarum@inbox.ru,
https://orcid.org/0001-0002-5845-588X
Anastasiya S. Bakharovskaya, student at the Department of Psychiatry, Narcology, Psychotherapy with a Course in General and Medical Psychology, Medical Institute named after S.I. Georgievsky of V.I. Vernadsky Crimean Federal University, 295051, Russia, Republic of Crimea, Simferopol, Lenin blvd., 5/7, +7(978)755-00-78, nastyabakharovskaya@gmail.com, https://orcid.org/0009-0002-1489-0289
Corresponding author: Anna N. Sulima, gsulima@yandex.ru
Similar Articles
